The Securities and Exchange Board of India (SEBI) has cleared the path for six major companies to launch their IPOs. While the Jindal Supreme (India) IPO was withdrawn. Here is an in-depth look at the latest SEBI IPO approval on 27 March 2026:

Shah Investor’s Home IPO Approval

Shah Investor’s Home is a prominent financial services and brokerage firm based in Ahmedabad. The company has filed its Draft Red Herring Prospectus (DRHP) on 30 September 2025 and secured its observation letter on 27 March 2026. The IPO is being managed by Beeline Capital Advisors, the IPO is structured as a fresh issue of 54,00,000 equity shares.

Operating under the brand “SIHL,” the company has built a strong regional footprint in Gujarat, providing a wide array of services, including equity brokerage, mutual fund distribution, and margin trading facilities. The proceeds from this fresh issue are primarily aimed at strengthening the company’s capital base and funding working capital requirements to scale its digital trading platforms like ‘SIHL Moneymaker’.

Vishvaraj Environment IPO Approval

Vishvaraj Environment is a leading player in the water utility and wastewater management sector. The company has filed its DRHP on 8 October 2025 and received the SEBI observation letter on 27 March 2026. The IPO is a fresh+OFS issue, sized at around INR 2,250 crore. This includes a fresh issue component of INR 1,250 crore and an OFS of INR 1,000 crore. JM Financial is the coordinating Lead Manager the issue.

The company is well-known for its Public-Private Partnership (PPP) projects in the water sector, including significant sewage treatment plants (STPs) in cities like Nagpur and upcoming projects for the 2027 Kumbh Mela. Vishvaraj Environment plans to utilise the fresh proceeds to fund capital expenditures for its subsidiaries, specifically for advanced water treatment plants.

Prasol Chemicals IPO Approval

Specialty chemicals manufacturer Prasol Chemicals has filed its preliminary papers on 27 October 2025. The company received its observation letter on 25 March 2026. The issue is managed by DAM Capital Advisors. Prasol Chemicals IPO is a Fresh + OFS type totaling INR 500 crore. The structure comprises a fresh issue of INR 80 crore and an offer for sale of INR 420 crore by existing shareholders.

Prasol Chemicals is an integrated manufacturer with a portfolio of over 150 products, specializing in acetone-based and phosphorus-based chemicals. It serves diverse industries, including home and personal care, pharmaceuticals, and agrochemicals.

SAEL Industries IPO Approval

In one of the most anticipated approvals this week, renewable energy powerhouse SAEL Industries has received the green light from SEBI. The company filed its DRHP on 6 November 2025 and secured its approval on 27 March 2026. The IPO has a total size of INR 4,575 crore, making it one of the largest in the current pipeline. The issue is a Fresh + OFS type, consisting of a substantial fresh issue of INR 3,750 crore and an OFS of INR 825 crore by Norfund. ICICI Securities Limited is leading the coordinating efforts for the IPO.

SAEL Industries is a vertically integrated renewable energy Independent Power Producer (IPP), specializing in biomass-based energy and solar power. It is currently India’s largest agri-waste-to-energy operator, turning crop residue into clean electricity.

NoPaperForms IPO Approval

Ed-tech SaaS platform NoPaperForms Solutions, popularly known for its flagship product ‘Meritto’, has received SEBI approval 25 March 2026. The company has confidentially filed its draft papers on 11 November 2025. Meritto IPO is being managed by IIFL Capital Services. The IPO is a fresh + OFS type. While the final size is yet to be confirmed in the RHP, market estimates peg the issue size between INR 500 – 600 crore.

Backed by Info Edge, NoPaperForms provides a unified SaaS platform for educational institutions to manage student acquisitions and enrollment lifecycles. It serves over 1,000 customers across India and international markets. The company has demonstrated impressive revenue growth as the education sector undergoes a digital transformation.

Symbiotec Pharmalab IPO Approval

Indore-based Symbiotec Pharmalab filed its DRHP on 23 December 2025 and received its observation letter on 25 March 2026. The offer includes a fresh issue of INR 150 crore and a significant OFS of INR 2,030 crore by promoters and investors like Rosewood Investments. JM Financial is the coordinating Lead Manager.

Symbiotec is a global leader in the production of corticosteroids and steroidal-hormone Active Pharmaceutical Ingredients (APIs). With over 30 years of experience and approvals from major global regulators like the US FDA and EU-GMP, the company holds a dominant market share in its specialized niche.

Jindal Supreme (India) IPO Withdrawal

While six companies celebrated approvals, Jindal Supreme (India). Jindal Supreme IPO is either withdrawn or returned. The company had submitted its draft papers for a fresh + OFS issue on 10 December 2025, but the issue was officially withdrawn on 23 March 2026. Sarthi Capital Advisors was managing the issue, which aimed to raise capital for its steel pipe and tube manufacturing operations. While the company has a solid presence in the infrastructure and agriculture sectors, the withdrawal suggests a strategic pause.

Rajat Bhati has a strong technical background and 5 years of experience in the stock market. He focuses on equity research, technical analysis, IPO valuations, and risk management, helping investors make clearer, data-backed decisions. Today, he works full-time to educate people about the opportunities in IPO market.